China
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.16 B
|
Dec. 31, 2023 | USD 1.02 | 0.45% |
|
China |
|
2 |
USD 1.79 B
|
Dec. 31, 2023 | USD 0.33 | -0.51% |
|
China |
|
3 |
USD 1.65 B
|
Dec. 31, 2023 | USD 0.24 | -1.77% |
|
China |
|
4 |
USD 335.08 M
|
Dec. 31, 2023 | USD 1.22 | 0.02% |
|
China |
|
5 |
USD 233.61 M
|
Dec. 31, 2023 | USD 0.34 | -4.40% |
|
China |
|
6 |
USD 214.11 M
|
Dec. 31, 2023 | USD 0.62 | -0.09% |
|
China |
|
7 |
USD 52.49 M
|
Dec. 31, 2023 | USD 0.17 | -0.09% |
|
China |
The Health Care REITs company in China with the highest Current Liabilities is Nanjing Gaoke Company Limited (Shanghai Stock Exchange: 600064.SS) at USD 2.16 B.
The Health Care REITs company in China with the lowest Current Liabilities is Zhongzhu Healthcare Holding Co.,Ltd (Shanghai Stock Exchange: 600568.SS) at USD 52.49 M.
The top 10 Health Care REITs companies in China by Current Liabilities are Nanjing Gaoke Company Limited, Citychamp Dartong Co.,Ltd., Shenzhen HeungKong Holding Co.,Ltd, JiangSu WuZhong Pharmaceutical Development Co., Ltd., Beijing Zodi Investment Co., Ltd., Beijing Centergate Technologies (holding) Co., Ltd. and Zhongzhu Healthcare Holding Co.,Ltd.
The bottom 10 Health Care REITs companies in China by Current Liabilities are Zhongzhu Healthcare Holding Co.,Ltd, Beijing Centergate Technologies (holding) Co., Ltd., Beijing Zodi Investment Co., Ltd., JiangSu WuZhong Pharmaceutical Development Co., Ltd., Shenzhen HeungKong Holding Co.,Ltd, Citychamp Dartong Co.,Ltd. and Nanjing Gaoke Company Limited.